Doxofylline Injection is a methylxanthine derivative used in the treatment of bronchial asthma, COPD and other obstructive airway disorders. Doxofylline has a safety profile with reduced adverse effects, making it suitable for patients who are sensitive to cardiovascular or CNS stimulation. This injectable formulation is especially useful for acute management in hospital settings where rapid bronchodilation is required.
Explore our diverse range of pharmaceutical manufacturing categories, designed to deliver high-quality, reliable, and innovative healthcare solutions across multiple dosage forms.
Corporate Office
Plot No. :46 First Floor, Industrial Area Phase-2, Chandigarh-160002, India.
Manufacturing Unit
Village Kondi, Post Thana, District Solan, Baddi 173205 Himachal Pradesh, India.
